Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Food Chem ; 267: 119-123, 2018 Nov 30.
Artigo em Inglês | MEDLINE | ID: mdl-29934145

RESUMO

Indospicine, a non-proteinogenic analogue of arginine, occurs only in Indigofera plant species and accumulates in the tissues of animals grazing on Indigofera. Canine deaths have resulted from the consumption of indospicine-contaminated meat but only limited information is available regarding indospicine toxicity in humans. In this study three human cell lines, Caco-2 (colorectal adenocarcinoma), HT29-MTX-E12 (colorectal adenocarcinoma) and HepG2 (hepatocellular carcinoma), were used to investigate the cytotoxicity of indospicine and its metabolite 2-aminopimelic acid in comparison to arginine. Indospicine and 2-aminopimelic acid were more cytotoxic than arginine, displaying the highest toxicity in HepG2 liver cells. Intestinal transport in vitro also revealed a 2-fold higher transport rate of indospicine compared to arginine. The sensitivity of HepG2 cells to indospicine is consistent with observed canine hepatotoxicity, and considering the higher in vitro transport of indospicine across an intestinal barrier, it is possible that similar ill effects could be seen in humans consuming contaminated meat.


Assuntos
Hepatócitos/efeitos dos fármacos , Mucosa Intestinal/metabolismo , Norleucina/análogos & derivados , Ácidos Pimélicos/toxicidade , Células CACO-2 , Linhagem Celular Tumoral , Colo , Contaminação de Alimentos , Células Hep G2 , Humanos , Indigofera/química , Mucosa Intestinal/efeitos dos fármacos , Carne/análise , Norleucina/farmacocinética , Norleucina/farmacologia , Norleucina/toxicidade , Ácidos Pimélicos/farmacocinética , Ácidos Pimélicos/farmacologia
2.
Toxicol Mech Methods ; 27(7): 518-527, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28552037

RESUMO

DON (6-diazo-5-oxo-l-norleucine), a glutamine antagonist, was demonstrated to exhibit analgesic, antibacterial, antiviral and anticancer properties. The study was performed to characterize its in vitro and in vivo genetic toxicity potential. DON was tested in the bacterial reverse mutation assay (Ames test) using Salmonella typhimurium tester strains (TA98, TA100, TA1535 and TA1537) and Escherichia coli tester strain (WP2 uvrA) with and without S9 and also with reductive S9. In addition, DON was tested for the chromosome aberrations in Chinese hamster ovary (CHO) cells with or without S9 to evaluate the clastogenic potential. Furthermore, DON was also evaluated for its in vivo clastogenic activity by detecting micronuclei in polychromatic erythrocyte (PCE) cells in bone marrow collected from the male mice dosed intravenously with 500, 100, 10, 1 and 0.1 mg/kg at 24 and 48-h post-dose. The Ames mutagenicity assay showed no positive mutagenic responses. However, the in vitro chromosome aberration assay demonstrated dose dependent statistically positive increase in structural aberrations at 4 and 20-h exposure without S9 and also at 4-h exposure with S9. The in vivo micronucleus assay also revealed a statistically positive response for micronucleus formation at 500, 100 and 10 mg/kg at 24 and 48-h post-dose. Thus, DON appears to be negative in the Ames test but positive in the in vitro chromosome aberration assay and in the in vivo micronucleus assay. In conclusion, the results indicate DON is a genotoxic compound with a plausible epigenetic mechanism.


Assuntos
Compostos Azo/toxicidade , Aberrações Cromossômicas/efeitos dos fármacos , Células Precursoras Eritroides/efeitos dos fármacos , Glutamina/antagonistas & inibidores , Mutagênicos/toxicidade , Neurotransmissores/toxicidade , Norleucina/análogos & derivados , Ativação Metabólica , Animais , Arocloros/farmacologia , Compostos Azo/administração & dosagem , Compostos Azo/metabolismo , Células CHO , Cricetinae , Cricetulus , Relação Dose-Resposta a Droga , Poluentes Ambientais/farmacologia , Masculino , Mesocricetus , Camundongos Endogâmicos ICR , Testes para Micronúcleos , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/enzimologia , Microssomos Hepáticos/metabolismo , Testes de Mutagenicidade , Mutagênicos/administração & dosagem , Mutagênicos/metabolismo , Neurotransmissores/administração & dosagem , Neurotransmissores/metabolismo , Norleucina/administração & dosagem , Norleucina/metabolismo , Norleucina/toxicidade , Ratos Sprague-Dawley , Testes de Toxicidade Aguda
3.
J Cell Physiol ; 87(3): 321-35, 1976 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-1254654

RESUMO

The selection of clones resistant to methionine antagonists was undertaken on baby hamster Kidney cells grown in a methionine free medium, supplemented with homocystine, folic acid and hydroxo-B12. Clones resistant to 30 mug/ml ethionine were isolated after mutagenesis at an induced mutation frequency of 2.3 X 10(-5). An ethionine resistant clone, ETH 304, was extensively studied. The resistant cells excreted methionine in the culture medium and the intracellular pools of methionine and SAM were two to five times greater in the resistant clone than in the wild type cells. A semidominant ethionine resistant phenotype was observed in hybrids between the wild type and this resistant clone. Measurement of the specific activity of menadione reductase, B12 methyltransferase and ATP: L-methionine S-adenosyl-transferase in crude extracts of the wild type showed a repressive action of methionine on the level of the three enzymes. However, the ethionine resistant clone ETH 304 was not modified in this function. Menadione reductase is feedback-inhibited by SAM in wild type cells. The enzyme of the ethionine resistant clone was significantly less sensitive to SAM. When a comparison of thermal stability was made between the wild type and ethionine resistant clone enzymes, it was found that the thermal stability of the latter was modified. Three other ethionine resistant clones, independantly isolated, were similarly affected in the properties of menadione reductase. These results suggest that the pathway of re-use of S-adenosyl homocysteine, produced during methylation reactions, is highly regulated by methionine and SAM.


Assuntos
Células Clonais/efeitos dos fármacos , Etionina/farmacologia , Metionina/metabolismo , 5-Metiltetra-Hidrofolato-Homocisteína S-Metiltransferase/metabolismo , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Resistência a Medicamentos , Etionina/metabolismo , Ácido Fólico/farmacologia , Homocisteína/metabolismo , Metionina/análogos & derivados , Metionina/farmacologia , Metionina Adenosiltransferase/metabolismo , Mutação , Norleucina/toxicidade , Quinona Redutases/metabolismo , Selenometionina/toxicidade , Vitamina K
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA